{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:56:01Z","timestamp":1781636161185,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Ministry of SMEs and Startups"},{"DOI":"10.13039\/501100003569","name":"the Ministry of Food and Drug Safety","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ipratropium bromide (IB), identified through an artificial intelligence (AI)-aided drug screening platform, was evaluated for its safety and efficacy in treating severe coronavirus disease 2019 (COVID-19) using a hamster model in this study. The mortality rates in the vehicle, remdesivir-treated, IB-treated, and IB-remdesivir combination treatment groups were 70%, 15%, 5%, and 50%, respectively. The IB-treated group showed significantly lower blood D-dimer levels and fibrin degradation product when compared to that in the vehicle group, indicating prevention of thrombosis-related complications. Histological examination also revealed reduced lung inflammation in the IB and combination groups, compared to that in the vehicle and remdesivir groups, with fewer neutrophils in bronchoalveolar lavage fluid. Moreover, IB may prevent thrombosis-related complications caused by severe COVID-19.<\/jats:p>","DOI":"10.1038\/s41598-025-27869-y","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T10:50:42Z","timestamp":1771498242000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of artificial intelligence identified ipratropium bromide for the treatment of coronavirus disease 2019"],"prefix":"10.1038","volume":"16","author":[{"given":"Dong-Sub","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungwoo","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choon-Mee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Won","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Jung","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hak","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonwoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na-Ra","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Rang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"27869_CR1","doi-asserted-by":"publisher","first-page":"102434","DOI":"10.1016\/j.jaut.2020.102434","volume":"109","author":"Y Yang","year":"2020","unstructured":"Yang, Y. et al. The deadly coronaviruses: the 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. J. Autoimmun. 109, 102434. https:\/\/doi.org\/10.1016\/j.jaut.2020.102434 (2020).","journal-title":"J. Autoimmun."},{"key":"27869_CR2","doi-asserted-by":"publisher","unstructured":"Muralidar, S., Ambi, S. V., Sekaran, S. & Krishnan, U. M. The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2. Biochimie. 179, 85\u2013100. https:\/\/doi.org\/10.1016\/j.biochi.2020.09.018 (2020).","DOI":"10.1016\/j.biochi.2020.09.018"},{"key":"27869_CR3","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.26355\/eurrev_202102_24877","volume":"25","author":"SA Meo","year":"2021","unstructured":"Meo, S. A., Bukhari, I. A., Akram, J., Meo, A. S. & Klonoff, D. C. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer\/BioNTech and moderna vaccines. Eur. Rev. Med. Pharmacol. Sci. 25, 1663\u20131669. https:\/\/doi.org\/10.26355\/eurrev_202102_24877 (2021).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"27869_CR4","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1002\/jmv.27697","volume":"94","author":"S Chenchula","year":"2022","unstructured":"Chenchula, S., Karunakaran, P., Sharma, S. & Chavan, M. Current evidence on efficacy of COVID-19 booster dose vaccination against the Omicron variant: A systematic review. J. Med. Virol. 94, 2969\u20132976. https:\/\/doi.org\/10.1002\/jmv.27697 (2022).","journal-title":"J. Med. Virol."},{"key":"27869_CR5","doi-asserted-by":"publisher","unstructured":"Farias, L. P. G. et al. Imaging findings in COVID-19 pneumonia. Clinics. 75, e2027. https:\/\/doi.org\/10.6061\/clinics\/2020\/e2027 (2020).","DOI":"10.6061\/clinics\/2020\/e2027"},{"key":"27869_CR6","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/his.14138","volume":"77","author":"Z Zeng","year":"2020","unstructured":"Zeng, Z. et al. Pulmonary pathology of early-phase COVID-19 pneumonia in a patient with a benign lung lesion. Histopathology 77, 823\u2013831. https:\/\/doi.org\/10.1111\/his.14138 (2020).","journal-title":"Histopathology"},{"key":"27869_CR7","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga, W. J. et al. Transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA 324, 782\u2013793. https:\/\/doi.org\/10.1001\/jama.2020.12839 (2020).","journal-title":"JAMA"},{"key":"27869_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3233\/JAD-200581","volume":"76","author":"M Fotuhi","year":"2020","unstructured":"Fotuhi, M., Mian, A., Meysami, S. & Raji, C. A. Neurobiology of COVID-19. J. Alzheimers Dis. 76, 3\u201319. https:\/\/doi.org\/10.3233\/JAD-200581 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"27869_CR9","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.cgh.2020.04.002","volume":"18","author":"Z Fan","year":"2020","unstructured":"Fan, Z. et al. Clinical features of COVID-19-related liver functional abnormality. Clin. Gastroenterol. Hepatol. 18, 1561\u20131566. https:\/\/doi.org\/10.1016\/j.cgh.2020.04.002 (2020).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"27869_CR10","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1080\/21505594.2021.1972201","volume":"12","author":"C Zhai","year":"2021","unstructured":"Zhai, C. et al. Roborovski hamster (Phodopus roborovskii) strain SH101 as a systemic infection model of SARS-CoV-2. Virulence 12, 2430\u20132442. https:\/\/doi.org\/10.1080\/21505594.2021.1972201 (2021).","journal-title":"Virulence"},{"key":"27869_CR11","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0140-6736(21)00896-5","volume":"398","author":"I Katsoularis","year":"2021","unstructured":"Katsoularis, I., Fonseca-Rodriguez, O., Farrington, P., Lindmark, K. & Fors Connolly, A. M. Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in sweden: a self-controlled case series and matched cohort study. Lancet 398, 599\u2013607. https:\/\/doi.org\/10.1016\/S0140-6736(21)00896-5 (2021).","journal-title":"Lancet"},{"key":"27869_CR12","doi-asserted-by":"publisher","first-page":"e069590","DOI":"10.1136\/bmj-2021-069590","volume":"377","author":"I Katsoularis","year":"2022","unstructured":"Katsoularis, I. et al. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study. BMJ 377, e069590. https:\/\/doi.org\/10.1136\/bmj-2021-069590 (2022).","journal-title":"BMJ"},{"key":"27869_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41392-022-01087-8","volume":"7","author":"C Fan","year":"2022","unstructured":"Fan, C. et al. Animal models for COVID-19: advances, gaps and perspectives. Signal. Transduct. Target. Ther. 7, 220. https:\/\/doi.org\/10.1038\/s41392-022-01087-8 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"27869_CR14","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1111\/bph.15143","volume":"177","author":"SJ Cleary","year":"2020","unstructured":"Cleary, S. J. et al. Animal models of mechanisms of SARS-CoV-2 infection and COVID-19 pathology. Br. J. Pharmacol. 177, 4851\u20134865. https:\/\/doi.org\/10.1111\/bph.15143 (2020).","journal-title":"Br. J. Pharmacol."},{"key":"27869_CR15","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1093\/cid\/ciaa325","volume":"71","author":"JF Chan","year":"2020","unstructured":"Chan, J. F. et al. Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in a golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clin. Infect. Dis. 71, 2428\u20132446. https:\/\/doi.org\/10.1093\/cid\/ciaa325 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"27869_CR16","doi-asserted-by":"publisher","first-page":"398","DOI":"10.30802\/AALAS-CM-21-000036","volume":"71","author":"AM Braxton","year":"2021","unstructured":"Braxton, A. M. et al. Hamsters as a model of severe acute respiratory syndrome Coronavirus-2. Comp. Med. 71, 398\u2013410. https:\/\/doi.org\/10.30802\/AALAS-CM-21-000036 (2021).","journal-title":"Comp. Med."},{"key":"27869_CR17","doi-asserted-by":"publisher","first-page":"406","DOI":"10.2500\/aap.2019.40.4258","volume":"40","author":"NT Agnihotri","year":"2019","unstructured":"Agnihotri, N. T. & Saltoun, C. Acute severe asthma (status asthmaticus). Allergy Asthma Proc. 40, 406\u2013409. https:\/\/doi.org\/10.2500\/aap.2019.40.4258 (2019).","journal-title":"Allergy Asthma Proc."},{"key":"27869_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1517\/17425251003649549","volume":"6","author":"J Gordon","year":"2010","unstructured":"Gordon, J. & Panos, R. J. Inhaled albuterol\/salbutamol and Ipratropium bromide and their combination in the treatment of chronic obstructive pulmonary disease. Expert Opin. Drug Metab. Toxicol. 6, 381\u2013392. https:\/\/doi.org\/10.1517\/17425251003649549 (2010).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"27869_CR19","doi-asserted-by":"publisher","first-page":"1203803","DOI":"10.3389\/fimmu.2023.1203803","volume":"21","author":"B Mi-Seon","year":"2023","unstructured":"Mi-Seon, B. et al. Evaluation of humoral immune response in relation to COVID-19 severity over 1 year post-infection: critical cases higher humaral immune response than mild cases. Front. Immunol. 21, 14:1203803. https:\/\/doi.org\/10.3389\/fimmu.2023.1203803 (2023).","journal-title":"Front. Immunol."},{"key":"27869_CR20","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0171-2985(84)80042-X","volume":"166","author":"AJ Ulmer","year":"1984","unstructured":"Ulmer, A. J., Scholz, W., Ernst, M., Brandt, E. & Flad, H. D. Isolation and subfractionation of human peripheral blood mononuclear cells (PBMC) by density gradient centrifugation on Percoll. Immunobiology 166, 238\u2013250. https:\/\/doi.org\/10.1016\/S0171-2985(84)80042-X (1984).","journal-title":"Immunobiology"},{"key":"27869_CR21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3164\/jcbn.20-128","volume":"68","author":"JM Park","year":"2021","unstructured":"Park, J. M. et al. Transcriptome profiling analysis of the response to walnut polyphenol extract in Helicobacter pylori-infected cells. J. Clin. Biochem. Nutr. 68, 201\u2013214. https:\/\/doi.org\/10.3164\/jcbn.20-128 (2021).","journal-title":"J. Clin. Biochem. Nutr."},{"issue":"4","key":"27869_CR22","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s12276-024-01189-z","volume":"56","author":"L Min Hak","year":"2024","unstructured":"Min Hak, L., Bada, L. & Eun, S. Transcriptoome-based deep learning analysis identifies drug candidates targeting protein synthesis and autophagy for the treatment of muscle wasting disorder. Exp. Mol. Med. 56 (4), 904\u2013921. https:\/\/doi.org\/10.1038\/s12276-024-01189-z (2024).","journal-title":"Exp. Mol. Med."},{"key":"27869_CR23","doi-asserted-by":"publisher","first-page":"W114","DOI":"10.1093\/nar\/gkab421","volume":"49","author":"H Nguyen","year":"2021","unstructured":"Nguyen, H. et al. CPA: a web-based platform for consensus pathway analysis and interactive visualization. Nucleic Acids Res. 49, W114\u2013W124. https:\/\/doi.org\/10.1093\/nar\/gkab421 (2021).","journal-title":"Nucleic Acids Res."},{"key":"27869_CR24","doi-asserted-by":"publisher","first-page":"W501","DOI":"10.1093\/nar\/gkx372","volume":"45","author":"W Luo","year":"2017","unstructured":"Luo, W., Pant, G., Bhavnasi, Y. K., Blanchard, S. G. Jr. & Brouwer, C. Pathview web: user friendly pathway visualization and data integration. Nucleic Acids Res. 45, W501\u2013W508. https:\/\/doi.org\/10.1093\/nar\/gkx372 (2017).","journal-title":"Nucleic Acids Res."},{"key":"27869_CR25","doi-asserted-by":"publisher","unstructured":"Karakiulakis, G. & Roth, M. Muscarinic receptors and their antagonists in COPD: anti-inflammatory and antiremodeling effects. Mediators Inflamm. 2012, 409580. https:\/\/doi.org\/10.1155\/2012\/409580 (2012).","DOI":"10.1155\/2012\/409580"},{"key":"27869_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ejphar.2009.11.015","volume":"628","author":"W Zhang","year":"2010","unstructured":"Zhang, W. et al. Anti-inflammatory effects of formoterol and Ipratropium bromide against acute cadmium-induced pulmonary inflammation in rats. Eur. J. Pharmacol. 628, 171\u2013178. https:\/\/doi.org\/10.1016\/j.ejphar.2009.11.015 (2010).","journal-title":"Eur. J. Pharmacol."},{"key":"27869_CR27","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s13054-020-03045-8","volume":"24","author":"S Tharakan","year":"2020","unstructured":"Tharakan, S., Nomoto, K., Miyashita, S. & Ishikawa, K. Body temperature correlates with mortality in COVID-19 patients. Crit. Care. 24, 298. https:\/\/doi.org\/10.1186\/s13054-020-03045-8 (2020).","journal-title":"Crit. Care"},{"key":"27869_CR28","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s00415-021-10837-7","volume":"269","author":"W Luo","year":"2022","unstructured":"Luo, W., Liu, X., Bao, K. & Huang, C. Ischemic stroke associated with COVID-19: a systematic review and meta-analysis. J. Neurol. 269, 1731\u20131740. https:\/\/doi.org\/10.1007\/s00415-021-10837-7 (2022).","journal-title":"J. Neurol."},{"key":"27869_CR29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ijcard.2022.12.032","volume":"372","author":"M Zuin","year":"2023","unstructured":"Zuin, M. et al. Increased risk of acute myocardial infarction after COVID-19 recovery: A systematic review and meta-analysis. Int. J. Cardiol. 372, 138\u2013143. https:\/\/doi.org\/10.1016\/j.ijcard.2022.12.032 (2023).","journal-title":"Int. J. Cardiol."},{"key":"27869_CR30","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1124\/jpet.108.145888","volume":"329","author":"M Profita","year":"2009","unstructured":"Profita, M. et al. Smoke, choline acetyltransferase, muscarinic receptors, and fibroblast proliferation in chronic obstructive pulmonary disease. J. Pharmacol. Exp. Ther. 329, 753\u2013763. https:\/\/doi.org\/10.1124\/jpet.108.145888 (2009).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"27869_CR31","doi-asserted-by":"publisher","first-page":"1185076","DOI":"10.3389\/fphar.2023.1185076","volume":"14","author":"Y Yu","year":"2023","unstructured":"Yu, Y., Fang, B., Yang, X. D. & Zheng, Y. One stone two birds: anti-inflammatory bronchodilators as a potential pharmacological strategy for COVID-19. Front. Pharmacol. 14, 1185076. https:\/\/doi.org\/10.3389\/fphar.2023.1185076 (2023).","journal-title":"Front. Pharmacol."},{"key":"27869_CR32","doi-asserted-by":"publisher","unstructured":"Mirabelli, C. et al. Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19. Proc. Natl. Acad. Sci. U S A. 118 https:\/\/doi.org\/10.1073\/pnas.2105815118 (2021).","DOI":"10.1073\/pnas.2105815118"},{"key":"27869_CR33","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1056\/NEJM198808253190806","volume":"319","author":"NJ Gross","year":"1988","unstructured":"Gross, N. J. Ipratropium bromide. N Engl. J. Med. 319, 486\u2013494. https:\/\/doi.org\/10.1056\/NEJM198808253190806 (1988).","journal-title":"N Engl. J. Med."},{"key":"27869_CR34","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s12079-021-00632-4","volume":"15","author":"DAB Rex","year":"2021","unstructured":"Rex, D. A. B., Dagamajalu, S., Kandasamy, R. K., Raju, R. & Prasad, T. S. K. SARS-CoV-2 signaling pathway map: A functional landscape of molecular mechanisms in COVID-19. J. Cell. Commun. Signal. 15, 601\u2013608. https:\/\/doi.org\/10.1007\/s12079-021-00632-4 (2021).","journal-title":"J. Cell. Commun. Signal."},{"issue":"6","key":"27869_CR35","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","volume":"80","author":"Y Qing","year":"2020","unstructured":"Qing, Y., Bili, W. & Jianhua, M. The pathogenesis and treatment of the \u2018Cytokine Storm; in COVID-19. J. infect. 80 (6), 607\u2013613 (2020).","journal-title":"J. infect."},{"key":"27869_CR36","doi-asserted-by":"publisher","first-page":"e32361","DOI":"10.7759\/cureus.32361","volume":"14","author":"AM Kyriakopoulos","year":"2022","unstructured":"Kyriakopoulos, A. M., Nigh, G., McCullough, P. A. & Seneff, S. Mitogen activated protein kinase (MAPK) Activation, p53, and autophagy Inhibition characterize the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike protein induced neurotoxicity. Cureus 14, e32361. https:\/\/doi.org\/10.7759\/cureus.32361 (2022).","journal-title":"Cureus"},{"key":"27869_CR37","doi-asserted-by":"publisher","first-page":"L709","DOI":"10.1152\/ajplung.00341.2013","volume":"306","author":"NR Aggarwal","year":"2014","unstructured":"Aggarwal, N. R., King, L. S. & D\u2019Alessio, F. R. Diverse macrophage populations mediate acute lung inflammation and resolution. Am. J. Physiol. Lung Cell. Mol. Physiol. 306, L709\u2013725. https:\/\/doi.org\/10.1152\/ajplung.00341.2013 (2014).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"27869_CR38","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00441-016-2562-z","volume":"367","author":"Z Zhou-Suckow","year":"2017","unstructured":"Zhou-Suckow, Z., Duerr, J., Hagner, M., Agrawal, R. & Mall, M. A. Airway mucus, inflammation and remodeling: emerging links in the pathogenesis of chronic lung diseases. Cell. Tissue Res. 367, 537\u2013550. https:\/\/doi.org\/10.1007\/s00441-016-2562-z (2017).","journal-title":"Cell. Tissue Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27869-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27869-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27869-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:29:11Z","timestamp":1781634551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27869-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["27869"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-27869-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"9 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dong-Sub Jung, Seungwoo Cheon, Jae-Hak Lee, Wonwoo Kim, Jihoon Kang and Yi Rang Kim are employed by Oncocross.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6980"}}